Dosage and administration
Apply to wet hair and massage into scalp. Leave on for 5 minutes and rinse thoroughly. For best results use at least twice a week or as directed by a doctor.
Apply to wet hair and massage into scalp. Leave on for 5 minutes and rinse thoroughly. For best results use at least twice a week or as directed by a doctor.
Drug Facts
Salicylic Acid 2%
Anti-Dandruff
Reduces scalp flaking, itching, and irritation associated with dandruff
For external use only
When using this product
avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.
Keep out of reach of children. If swallowed, get medical help or contact a poison control right away.
Water, cocamidopropyl betaine, sodium C14-16 olefin sulfonate, glycerin, sodium lauroyl methyl isethionate, polysorbate 80, acrylates copolymer, fragrance, propanediol caprylate, potassium hydroxide, sodium methyl oleoyl taurate, sodium benzoate, polyquaternium-113, sodium cocoyl isethionate, cocamide MIPA, chlorphenesin, silicone quaternium-22, tetrasodium EDTA, polyglyceryl-3 caprate, epilobium angustifolium flower/leaf/stem extract, PEG-45m, palmitamidopropyltrimonium chloride
1 (888) 450-OUAI
DIST. BY OUAI BEVERLY HILLS,
CA 90210 USA
OUAI
SALICYLIC ACID 2%
ANTI-DANDRUFF SHAMPOO
10 fl oz / 300 ml
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84126-905 | 84126-905-30 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ouai Anti-Dandruff | SALICYLIC ACID | The Procter & Gamble Manufacturing Company | 5990c45f-f653-b403-e063-6394a90a329d | 2026-08-21 | Warnings | 84126-905-30 84126-905 84126090530 5990c429-ed1b-c76b-e063-6294a90a40d0 5990c45f-f653-b403-e063-6394a90a329d |
Adverse event summaries are temporarily unavailable. Other product information remains available.